Moran Kyle's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Aug 23, 2023
- Accession no.
- 0000899243-23-018361
- Filed
- Aug 23, 2023
- Trade date
- Aug 23, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $176.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moran KyleCIK 0001657765 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 | Ordinary Shares | SSaleDisposed | −37,062 | $4.75 | −$176,044.5 | 46,120 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.